First week of the month is "always very important" due to the pending jobs data, says Kevin Hincks. He and Nicole Petallides recap a busy weekend with market participants reacting to ongoing developments in the Middle East weighing on crude oil, U.S. Treasury intervention impacting the Japanese Yen and a pullback in yields. Later, he weighs in on reported merger discussions between AstraZeneca (AZN) and Bristol Myers Squibb (BMY).